Beth Helmink

Beth Helmink is an Assistant Professor at The University of Texas MD Anderson Cancer Center, specializing in surgical oncology and gastrointestinal oncology. Her research focuses on cancer immunotherapy, immunology, and the molecular characterization of appendiceal adenocarcinoma, including genomic profiling across histological subtypes and spatial proteomics of immune aggregates as predictive biomarkers. Recent publications include studies on KRAS inhibition efficacy, perioperative serum tumor markers, and organoid modeling of goblet cell subtypes. Her work integrates pathology, radiation oncology, and translational immunology to refine surgical and adjuvant treatment strategies.